EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Genesystem Co's Enterprise Value is ₩34,144.8 Mil.
Genesystem Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-8,230.3 Mil. Therefore, Genesystem Co's EV-to-FCF for today is -4.15.
The historical rank and industry rank for Genesystem Co's EV-to-FCF or its related term are showing as below:
XKRX:363250'
s EV-to-FCF Range Over the Past 10 Years
Min: -71.1 Med: -5.41 Max: 255.86
Current: -4.06
During the past 5 years, the highest EV-to-FCF of Genesystem Co was 255.86. The lowest was -71.10. And the median was -5.41.
XKRX:363250's EV-to-FCF is ranked worse than 100% of 100
companies
in the Medical Diagnostics & Research industry
Industry Median: 27.12
vs XKRX:363250: -4.06
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Genesystem Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Genesystem Co's EV-to-FCF
For the Diagnostics & Research subindustry, Genesystem Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genesystem Co's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Genesystem Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Genesystem Co's EV-to-FCF falls into.
Genesystem Co EV-to-FCF Calculation
Genesystem Co's EV-to-FCF for today is calculated as:
Genesystem Co's current Enterprise Value is ₩34,144.8 Mil.
Genesystem Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-8,230.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genesystem Co (XKRX:363250) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Genesystem Co's PE Ratio for today is calculated as:
Genesystem Co's share price for today is ₩6300.00.
Genesystem Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1138.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Genesystem Co EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Genesystem Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:363250 has been successfully added to your 